Other
Pediatric
0
Pipeline Programs↗
41
Active Trials↗
51
Companies Involved↗
Pediatric is an early-stage landscape with 0 programs across 51 companies. The most active players are Eisai, GSK, Sumitomo Pharma America, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
271
clinical trials
Completed182 · 67%
Terminated26 · 10%
Recruiting25 · 9%
Unknown status13 · 5%
Withdrawn9 · 3%
Active, not recruiting8 · 3%
Other8 · 3%
Clinical Trials
Trial Activity
271 trials
Psyllium in Pediatric IBS
Recruiting·—·Phase 2·NCT06639984·110 enrolled
GD2-CAR T Cells for Pediatric Brain Tumours
Recruiting·—·Phase 1·NCT05298995·54 enrolled
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
Recruiting·—·Phase 4·NCT02044497·68 enrolled
Page 1 of 19
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)